Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients

2014 ◽  
Vol 41 (11) ◽  
pp. 7555-7565 ◽  
Author(s):  
Feng Liu ◽  
Xiaobin Mei ◽  
Yingying Zhang ◽  
Hualin Qi ◽  
Jun Wang ◽  
...  
2006 ◽  
Vol 124 (1) ◽  
pp. 36-41 ◽  
Author(s):  
José Jayme Galvão de Lima

Cardiovascular disease is the main cause of death among hemodialysis patients. Although uremia by itself may be considered to be a cardiovascular risk factor, a significant proportion of dialysis patients die because of cardiovascular disease not directly attributable to uremia. Indeed, many of the cardiovascular diseases and cardiovascular risk factors in these patients are common to those occurring in the general population and are amenable to intervention. Lack of proper medical care during the early stages of renal insufficiency and present-day dialysis routines, by failing to correct hypertension, hypervolemia and left ventricular hypertrophy in many patients, may also add to the cardiovascular burden. The author suggests that, in addition to early treatment and referral to a specialist, chronic renal failure patients should undergo intensive cardiovascular screening and treatment, and correction of cardiovascular risk factors based on guidelines established for the general population.


2015 ◽  
Vol 18 (9) ◽  
pp. 941-949 ◽  
Author(s):  
Pei-Tzu Wu ◽  
Peter J. Fitschen ◽  
Brandon M. Kistler ◽  
Jin Hee Jeong ◽  
Hae Ryong Chung ◽  
...  

Nephron ◽  
2016 ◽  
Vol 132 (4) ◽  
pp. 317-326 ◽  
Author(s):  
Patrícia João Matias ◽  
Cristina Jorge ◽  
Ana Azevedo ◽  
Ivo Laranjinha ◽  
David Navarro ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document